Company intelligence / Profile preview

P Company

Minato-ku, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

P-Company is a Japanese biotechnology company specializing in the field of regenerative medicine and cell therapy. The company focuses on the development and commercialization of autologous cell processing technologies, particularly for immune cell therapy and stem cell applications. P-Company provides comprehensive support for medical institutions, including the establishment of cell processing centers (CPCs) and the provision of specialized culture media and protocols. Their business model integrates clinical research support with the practical application of advanced cellular therapies to treat cancer and age-related chronic conditions.

Therapeutic areas: OncologyImmunologyOther
Modalities: Cell therapyRegenerative medicine
Industry: Biotech

Partnerships

Various Japanese Medical UniversitiesLocal Cell Processing Centers

Beyond the preview

Go deeper on P Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on P Company.

Explore the full profile